Japan PhI/II of GSK2118436 and GSK1120212 Combination in Subjects With BRAF V600E/K Mutation Positive Advanced Solid Tumors (Phase I Part) or Cutaneous Melanoma (Phase II Part)
Clinical trial NCT01928940 · COMPLETED
Trial details
- NCT number
- NCT01928940
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-15
- Primary completion
- 2014-09-18
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.